{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:40:42Z","timestamp":1778823642944,"version":"3.51.4"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the etiology spectrum and complication profiles of hospitalized children with chronic kidney disease (CKD) stages 3\u20135, identify independent risk factors for CKD progression, and provide evidence for optimizing early clinical management. We hypothesized that congenital anomalies of the kidney and urinary tract (CAKUT) are the predominant etiology in this cohort, and baseline eGFR decline plus uncontrolled hypertension would independently predict progression to stage 5 CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted on 170 children with CKD stages 3\u20135 admitted to the Nephrology Department of Beijing Children's Hospital from January 2016 to December 2023. Etiology, complication rates, and their associations with CKD stages were analyzed. Multivariate logistic regression models were used to identify independent risk factors for progression to stage 5 CKD, adjusting for age, sex, and underlying etiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CAKUT accounted for 51.8% of cases, followed by glomerular diseases (22.4%). The prevalence of anemia (80.5%), hypertension (64.1%), and CKD-MBD (90.6%) increased significantly with CKD progression (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001 for all). Anemia occurred in 100% of stage 5 non-dialysis patients, while hypertension control rates were only 45.3%. Multivariate analysis identified baseline eGFR &amp;lt;30\u2005mL\/min\/1.73\u2005m\u00b2 (OR\u2009=\u20094.2, 95% CI: 2.1\u20138.3,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and uncontrolled hypertension (OR\u2009=\u20092.5, 95% CI: 1.5\u20134.2,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001) as independent predictors of progression to stage 5 CKD. The overall infection rate was 28.2%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CAKUT is the leading etiology of CKD stages 3\u20135 in hospitalized children, with a high burden of complications. Early intervention for anemia, hypertension, and CKD-MBD, combined with enhanced infection prevention, may improve clinical outcomes. Baseline eGFR &amp;lt;30\u2005mL\/min\/1.73\u2005m\u00b2 and uncontrolled hypertension are key targets for delaying CKD progression. Notably, the distribution of etiology and complication burden in this cohort parallels patterns reported in North America and Europe, supporting the global applicability of KDIGO-based management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1712781","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:40:00Z","timestamp":1774593600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-center analysis of etiology and complications in hospitalized children with chronic kidney disease stages 3\u20135"],"prefix":"10.3389","volume":"14","author":[{"given":"Ying","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Beijing Children\u2019s Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Beijing Children\u2019s Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeping","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Beijing Children\u2019s Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"A8","DOI":"10.1053\/j.ajkd.2022.12.001","article-title":"US renal data system 2022 annual data report: epidemiology of kidney disease in the United States","volume":"81","author":"Johansen","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"key":"B4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.ajkd.2013.06.008","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for Anemia in CKD","volume":"62","author":"Kliger","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00467-013-2684-4","article-title":"Single-gene causes of congenital anomalies of the kidney and urinary tract (CAKUT) in humans","volume":"29","author":"Vivante","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2215\/CJN.06260614","article-title":"Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort","volume":"10","author":"Trautmann","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00467-017-3663-y","article-title":"Anemia in chronic kidney disease","volume":"33","author":"Atkinson","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2215\/CJN.03850609","article-title":"Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease","volume":"5","author":"Sprague","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40620-017-0424-8","article-title":"Update on the role of bone biopsy in the management of patients with CKD-MBD","volume":"30","author":"Evenepoel","year":"2017","journal-title":"J Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.12809\/hkmj154781","article-title":"Chronic peritoneal dialysis in Chinese infants and children younger than two years","volume":"22","author":"Chan","year":"2016","journal-title":"Hong Kong Med J"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1712781\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:40:00Z","timestamp":1774593600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1712781\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":11,"alternative-id":["10.3389\/fped.2026.1712781"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1712781","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1712781"}}